Latest Insider Transactions at Biolife Solutions Inc (BLFS)
This section provides a real-time view of insider transactions for Biolife Solutions Inc (BLFS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BIOLIFE SOLUTIONS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BIOLIFE SOLUTIONS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
830
-0.23%
|
$19,090
$23.02 P/Share
|
|
Sep 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
657
-0.26%
|
$15,111
$23.02 P/Share
|
|
Sep 23
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
569
-1.24%
|
$11,949
$21.91 P/Share
|
|
Sep 01
2022
|
Timothy L. Moore Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,589
+50.0%
|
-
|
|
Aug 31
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
425
-0.17%
|
$9,775
$23.44 P/Share
|
|
Aug 31
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
299
-0.27%
|
$6,877
$23.44 P/Share
|
|
Aug 31
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
906
-0.25%
|
$20,838
$23.44 P/Share
|
|
Aug 31
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
51
-0.11%
|
$1,173
$23.44 P/Share
|
|
Aug 16
2022
|
Troy Wichterman Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
116
-0.25%
|
$2,784
$24.81 P/Share
|
|
Aug 14
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
535
+0.42%
|
-
|
|
Aug 14
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
411
+0.16%
|
-
|
|
Aug 14
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
278
+0.25%
|
-
|
|
Aug 14
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
504
+0.14%
|
-
|
|
Aug 14
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
234
+0.51%
|
-
|
|
Aug 10
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
112
-0.04%
|
$2,576
$23.17 P/Share
|
|
Aug 10
2022
|
Karen A. Foster Chief Quality and Operations |
SELL
Open market or private sale
|
Direct |
95
-0.09%
|
$2,185
$23.17 P/Share
|
|
Aug 10
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
42
-0.12%
|
$966
$23.17 P/Share
|
|
Aug 10
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
171
-0.05%
|
$3,933
$23.17 P/Share
|
|
Aug 10
2022
|
Todd Berard Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
52
-0.05%
|
$1,196
$23.17 P/Share
|
|
Aug 10
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
40
-0.12%
|
$920
$23.17 P/Share
|
|
Aug 03
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
4,600
-11.27%
|
$92,000
$20.03 P/Share
|
|
Aug 01
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
295
+1.4%
|
-
|
|
Aug 01
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
311
+1.26%
|
-
|
|
Aug 01
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
280
+1.48%
|
-
|
|
Aug 01
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
259
+1.24%
|
-
|
|
Jul 29
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
524
+0.21%
|
-
|
|
Jul 29
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
355
+0.32%
|
-
|
|
Jul 29
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
643
+0.18%
|
-
|
|
Jul 29
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
683
+0.54%
|
-
|
|
Jul 29
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
299
+0.65%
|
-
|
|
Jul 22
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
367
-0.89%
|
$6,239
$17.94 P/Share
|
|
Jul 22
2022
|
Sarah Aebersold Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
252
-0.77%
|
$4,284
$17.85 P/Share
|
|
Jul 17
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
828
+0.66%
|
-
|
|
Jul 17
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
430
+0.39%
|
-
|
|
Jul 17
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
779
+0.21%
|
-
|
|
Jul 17
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
635
+0.25%
|
-
|
|
Jul 17
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
362
+0.79%
|
-
|
|
Jul 12
2022
|
Roderick De Greef President and CEO |
SELL
Open market or private sale
|
Direct |
9,158
-6.85%
|
$137,370
$15.79 P/Share
|
|
Jul 12
2022
|
Marcus Schulz Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
254
-0.61%
|
$3,810
$15.79 P/Share
|
|
Jul 03
2022
|
Roderick De Greef President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
900
+0.67%
|
-
|
|
Jul 03
2022
|
Michael Rice |
BUY
Grant, award, or other acquisition
|
Direct |
847
+0.23%
|
-
|
|
Jul 03
2022
|
Troy Wichterman Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
394
+0.86%
|
-
|
|
Jul 03
2022
|
Karen A. Foster Chief Quality and Operations |
BUY
Grant, award, or other acquisition
|
Direct |
468
+0.43%
|
-
|
|
Jul 03
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
690
+0.27%
|
-
|
|
Jul 01
2022
|
Joseph C Schick Director |
BUY
Grant, award, or other acquisition
|
Direct |
409
+1.67%
|
-
|
|
Jul 01
2022
|
Rachel Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
341
+1.65%
|
-
|
|
Jul 01
2022
|
Amy Du Ross Director |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.87%
|
-
|
|
Jul 01
2022
|
Joydeep Goswami Director |
BUY
Grant, award, or other acquisition
|
Direct |
369
+1.97%
|
-
|
|
Jun 28
2022
|
Michael Rice |
SELL
Open market or private sale
|
Direct |
889
-0.25%
|
$12,446
$14.86 P/Share
|
|
Jun 28
2022
|
Aby J. Mathew EVP & Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
704
-0.28%
|
$9,856
$14.86 P/Share
|